Dong-a St Co., Ltd.
Clinical trials sponsored by Dong-a St Co., Ltd., explained in plain language.
-
New diabetes drug DA-5218 aims to help when metformin Isn't enough
Disease control Not yet recruitingThis phase 4 trial tests an experimental drug called DA-5218 in 238 adults with type 2 diabetes whose blood sugar is not well controlled by metformin alone. Participants will receive either DA-5218 or an active comparator, and researchers will measure changes in HbA1c (a key bloo…
Phase: PHASE4 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
New diabetes drug combo aims to tame blood sugar
Disease control Not yet recruitingThis study tests whether adding a new drug called DA-2811 to standard diabetes medications helps lower blood sugar more effectively in people with type 2 diabetes. About 288 adults with poorly controlled diabetes will receive either DA-2811 or a placebo alongside their usual trea…
Phase: PHASE2 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated Jun 18, 2026 11:53 UTC
-
Healthy volunteers needed to test drug equivalence
Knowledge-focused Not yet recruitingThis study aims to see if two versions of a drug, DA-5230 and DA-5230-R, are absorbed and processed by the body in the same way. It involves 60 healthy adults aged 19 to 55 who will receive a single dose of each version on separate days. The results will help determine if the two…
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:04 UTC